全球低介入性脊椎壓迫性骨折治療市場動向：2007年

Abstract

The global market for minimally invasive vertebral compression fracture treatments was valued at over $460 million in 2006.

This market comprises devices used in vertebroplasty and kyphoplasty procedures in the US, Europe, and Asia Pacific regions.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 VERTEBRAL COMPRESSION FRACTURE OVERVIEW

• 1.1 Anatomy of the Human Spine
• 1.2 Selected Spinal Disorders
  • 1.2.1 Osteoporosis
  • 1.2.2 Rheumatoid Arthritis
  • 1.2.3 Kyphosis
  • 1.2.4 Traumatic Spine Disorders
  • 1.2.5 Spinal Tumor Disorders
• 1.3 Vertebral Compression Fractures
  • 1.3.1 Treatment Options
    • 1.3.1.1 Nonsurgical
    • 1.3.1.2 Surgical
    • 1.3.1.3 Noninvasive Approach
• 1.4 Vertebroplasty
  • 1.4.1 Approach
  • 1.4.2 Mechanism of Action
  • 1.4.3 Potential Complications
  • 1.4.4 Indications/Contraindications
• 1.5 Kyphoplasty
• 1.6 Vertebroplasty versus Kyphoplasty
• 1.7 Injectable Bone Cement
• 1.8 Cement Delivery Systems

2.0 GLOBAL MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Procedures
  • 2.2.2 Market Forecast
  • 2.2.3 Market Drivers & Limiters
    • 2.2.3.1 Market Drivers
    • 2.2.3.2 Market Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Emerging Competitors

3.0 US MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Procedures
  • 3.2.2 Market Forecast
  • 3.2.3 Market Drivers and Limiters
    • 3.2.3.1 Market Drivers
    • 3.2.3.2 Market Limiters
• 3.3 Competitive Analysis

4.0 EUROPEAN MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedures
  • 4.2.2 Market Forecast
  • 4.2.3 Market Drivers and Limiters
    • 4.2.3.1 Market Drivers
    • 4.2.3.2 Market Limiters
• 4.3 Competitive Analysis
• 4.4 French Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 4.4.1 Market Analysis
  • 4.4.2 Market Drivers and Limiters
    • 4.4.2.1 Market Drivers
    • 4.4.2.2 Market Limiters
  • 4.4.3 Competitive Analysis
• 4.5 German Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 4.5.1 Market Analysis
  • 4.5.2 Market Drivers and Limiters
    • 4.5.2.1 Market Drivers
    • 4.5.2.2 Market Limiters
  • 4.5.3 Competitive Analysis
• 4.6 Italian Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 4.6.1 Market Analysis
  • 4.6.2 Market Drivers and Limiters
    • 4.6.2.1 Market Drivers
    • 4.6.2.2 Market Limiters
  • 4.6.3 Competitive Analysis
• 4.7 UK Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 4.7.1 Market Analysis
  • 4.7.2 Market Drivers and Limiters
    • 4.7.2.1 Market Drivers
    • 4.7.2.2 Market Limiters
  • 4.7.3 Competitive Analysis

5.0 ASIA PACIFIC MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Procedures
  • 5.2.2 Market Forecast
  • 5.2.3 Market Drivers and Limiters
    • 5.2.3.1 Market Drivers
    • 5.2.3.2 Market Limiters
• 5.3 Competitive Analysis
• 5.4 Australian Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 5.4.1 Market Analysis
  • 5.4.2 Market Drivers and Limiters
    • 5.4.2.1 Market Drivers
    • 5.4.2.2 Market Limiters
  • 5.4.3 Competitive Analysis
• 5.5 Japanese Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 5.5.1 Market Analysis
  • 5.5.2 Market Drivers and Limiters
    • 5.5.2.1 Market Drivers
    • 5.5.2.2 Market Limiters
  • 5.5.3 Competitive Analysis
• 5.6 South Korean Minimally Invasive Vertebral Compression Fracture Treatment Market
  • 5.6.1 Market Analysis
  • 5.6.2 Market Drivers and Limiters
    • 5.6.2.1 Market Drivers
    • 5.6.2.2 Market Limiters
  • 5.6.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS & INITIALISMS

APPENDIX B: OSTEOPOROSIS EPIDEMIOLOGY

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: MIVCF Treatment Market, by Region, Global (US$), 2005-2011
• Exhibit 2: Kyphoplasty Procedures, Global, 2005-2011
• Exhibit 3: Vertebroplasty Procedures, Global, 2005-2011
• Exhibit 4: MIVCF Treatment Market, by Segment, US (US$), 2005-2011
• Exhibit 5: MIVCF Treatment Market, as a % of Total, by Country, Europe, 2005-2011
• Exhibit 6: MIVCF Treatment Market, by Segment, Asia Pacific (US$), 2005-2011
• Exhibit 7: Leading Competitors in the MIVCF Market, Global, 2006

METHODOLOGY

• Exhibit 8: Currency Exchange Rates, 2006

CHAPTER 1: VERTEBRAL COMPRESSION FRACTURE OVERVIEW

• Exhibit 9: Roles of the Spinal Column
• Exhibit 10: Potential Complications of Vertebroplasty
• Exhibit 11: Selected Contraindications to Vertebroplasty
• Exhibit 12: Vertebroplasty versus Kyphoplasty
• Exhibit 13: Selected Bone Cement for MIVCF treatments
• Exhibit 14: Selected Cement Delivery Systems and Accessories

CHAPTER 2: GLOBAL MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• Exhibit 15: MIVCF Treatment Market, Global, 2005-2011
• Exhibit 16: MIVCF Treatment Procedures, By Segment, Global, 2005-2011
• Exhibit 17: MIVCF Treatment Procedures, By Segment and by Region, Global, 2005-2011
• Exhibit 18: Total MIVCF Treatment Procedures, by Region, Global, 2005-2011
• Exhibit 19: MIVCF Market, By Segment, Global (US$), 2005-2011
• Exhibit 20: MIVCF Treatment Market, by Segment and Region, Global (US$), 2005-2011
• Exhibit 21: Total MIVCF Treatment Market, by Region, Global (US$), 2005-2011
• Exhibit 22: Drivers and Limiters of the MIVCF Market, Global
• Exhibit 23: Leading Competitors in the MIVCF Market, by Segment, as a % of Total, Global, 2006
• Exhibit 24: Leading Competitors in the Vertebroplasty Market, as a % of Total, Global, 2006
• Exhibit 25: Kyphon Clinical Trials, Global, 2006

CHAPTER 3: US MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• Exhibit 26: MIVCF Treatment Procedures, by Segment, US, 2005-2011 (Graphical Format)
• Exhibit 27: MIVCF Treatment Procedures, by Segment, US, 2005-2011 (Tabular Format)
• Exhibit 28: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, US, 2005-2011
• Exhibit 29: MIVCF Treatment Levels, by Segment, US, 2005-2011
• Exhibit 30: MIVCF Treatment Market, by Segment, US (US$), 2005-2011
• Exhibit 31: MIVCF Market Growth, by Segment, US, 2006-2011
• Exhibit 32: MIVCF Treatment ASP, by Segment and Component, US (US$), 2005-2011
• Exhibit 33: MIVCF Treatment Bone Cement Market, by Segment, US (US$), 2005-2011
• Exhibit 34: MIVCF Treatment Delivery System Market, by Segment, US (US$), 2005-2011
• Exhibit 35: Drivers of the MIVCF Treatment Market, US
• Exhibit 36: Limiters of the MIVCF Treatment Market, US
• Exhibit 37: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, US, 2006
• Exhibit 38: Leading Competitors in the MIVCF Treatment Bone Cement Market, by Segment, as a % of Total, US, 2006
• Exhibit 39: Leading Competitors in the MIVCF Treatment Delivery Systems Market, by Segment, as a % of Total, US, 2006

CHAPTER 4: EUROPEAN MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• Exhibit 40: MIVCF Treatment Market, by Country, Europe (US$), 2005-2011
• Exhibit 41: MIVCF Treatment Procedures, by Segment, Europe, 2005-2011
• Exhibit 42: MIVCF Treatment Procedures, by Segment and Country, Europe, 2005-2011
• Exhibit 43: Total MIVCF Treatment Procedures, by Country, Europe, 2005-2011
• Exhibit 44: MIVCF Treatment Levels, by Segment, Europe, 2005-2011
• Exhibit 45: MIVCF Treatment Market, by Segment, Europe, (US$ and €), 2005-2011
• Exhibit 46: Vertebroplasty Market, by Country, Europe (US$ and €), 2005-2011
• Exhibit 47: Kyphoplasty Market, by Country, Europe (US$ and €), 2005-2011
• Exhibit 48: MIVCF Treatment Bone Cement Market, by Segment, Europe, (US$ and €), 2005-2011
• Exhibit 49: MIVCF Treatment Delivery Systems Market, by Segment, Europe, (US$ and €), 2005-2011
• Exhibit 50: MIVCF Treatment Bone Cement Market, by Country, Europe (US$ and €), 2005-2011
• Exhibit 51: MIVCF Treatment Delivery Systems Market, by Country, Europe (US$ and €), 2005-2011
• Exhibit 52: Drivers and Limiters of the MIVCF Treatment Market, Europe
• Exhibit 53: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Europe, 2006
• Exhibit 54: Leading Competitors in the MIVCF Treatment Market, by Country, as a % of Total, Europe, 2006
• Exhibit 55: MIVCF Treatment Procedures, by Segment, France, 2005-2011
• Exhibit 56: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, France, 2005-2011
• Exhibit 57: MIVCF Treatment Levels, by Segment, France, 2005-2011
• Exhibit 58: MIVCF Treatment Market, by Segment, France (US$ and €), 2005-2011
• Exhibit 59: MIVCF Market Growth, by Segment, France, 2006-2011
• Exhibit 60: MIVCF Treatment ASP, by Segment and Component, France (US$ and €), 2005-2011
• Exhibit 61: MIVCF Treatment Bone Cement Market, by Segment, France (US$), 2005-2011
• Exhibit 62: MIVCF Treatment Bone Cement Market, by Segment, France (€), 2005-2011
• Exhibit 63: MIVCF Treatment Delivery Systems Market, by Segment, France (US$), 2005-2011
• Exhibit 64: MIVCF Treatment Delivery Systems Market, by Segment, France (€), 2005-2011
• Exhibit 65: Drivers of the MIVCF Treatment Market, France
• Exhibit 66: Limiters of the MIVCF Treatment Market, France
• Exhibit 67: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, France, 2006
• Exhibit 68: MIVCF Treatment Procedures, by Segment, Germany, 2005-2011
• Exhibit 69: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, Germany, 2005-2011
• Exhibit 70: MIVCF Treatment Levels, by Segment, Germany, 2005-2011
• Exhibit 71: MIVCF Treatment Market, by Segment, Germany (US$ and €), 2005-2011
• Exhibit 72: MIVCF Market Growth, by Segment, Germany, 2006-2011
• Exhibit 73: MIVCF Treatment ASP, by Segment and Component, Germany (US$ and €), 2005-2011
• Exhibit 74: MIVCF Treatment Bone Cement Market, by Segment, Germany (US$), 2005-2011
• Exhibit 75: MIVCF Treatment Bone Cement Market, by Segment, Germany (€), 2005-2011
• Exhibit 76: MIVCF Treatment Delivery Systems Market, by Segment, Germany (US$), 2005-2011
• Exhibit 77: MIVCF Treatment Delivery Systems Market, by Segment, Germany (€), 2005-2011
• Exhibit 78: Drivers of the MIVCF Treatment Market, Germany
• Exhibit 79: Limiters of the MIVCF Treatment Market, Germany
• Exhibit 80: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Germany, 2006
• Exhibit 81: MIVCF Treatment Procedures, by Segment, Italy, 2005-2011
• Exhibit 82: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, Italy, 2005-2011
• Exhibit 83: MIVCF Treatment Levels, by Segment, Italy, 2005-2011
• Exhibit 84: MIVCF Treatment Market, by Segment, Italy (US$ and €), 2005-2011
• Exhibit 85: MIVCF Market Growth, by Segment, Italy, 2006-2011
• Exhibit 86: MIVCF Treatment ASP, by Segment and Component, Italy (US$ and €), 2005-2011
• Exhibit 87: MIVCF Treatment Bone Cement Market, by Segment, Italy (US$), 2005-2011
• Exhibit 88: MIVCF Treatment Bone Cement Market, by Segment, Italy (€), 2005-2011
• Exhibit 89: MIVCF Treatment Delivery Systems Market, by Segment, Italy (US$), 2005-2011
• Exhibit 90: MIVCF Treatment Delivery Systems Market, by Segment, Italy (€), 2005-2011
• Exhibit 91: Drivers of the MIVCF Treatment Market, Italy
• Exhibit 92: Limiters of the MIVCF Treatment Market, Italy
• Exhibit 93: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Italy, 2006
• Exhibit 94: MIVCF Treatment Procedures, by Segment, UK, 2005-2011
• Exhibit 95: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, UK, 2005-2011
• Exhibit 96: MIVCF Treatment Levels, by Segment, UK, 2005-2011
• Exhibit 97: MIVCF Treatment Market, by Segment, UK (US$), 2005-2011
• Exhibit 98: MIVCF Treatment Market, by Segment, UK (€), 2005-2011
• Exhibit 99: MIVCF Treatment Market, by Segment, UK (£), 2005-2011
• Exhibit 100: MIVCF Market Growth, by Segment, UK, 2006-2011
• Exhibit 101: MIVCF Treatment ASP, by Segment and Component, UK (US$, €, and £), 2005-2011
• Exhibit 102: MIVCF Treatment Bone Cement Market, by Segment, UK (US$), 2005-2011
• Exhibit 103: MIVCF Treatment Bone Cement Market, by Segment, UK (€), 2005-2011
• Exhibit 104: MIVCF Treatment Bone Cement Market, by Segment, UK (£), 2005-2011
• Exhibit 105: MIVCF Treatment Delivery Systems Market, by Segment, UK (US$), 2005-2011
• Exhibit 106: MIVCF Treatment Delivery Systems Market, by Segment, UK (€), 2005-2011
• Exhibit 107: MIVCF Treatment Delivery Systems Market, by Segment, UK (£), 2005-2011
• Exhibit 108: Drivers of the MIVCF Treatment Market, UK
• Exhibit 109: Limiters of the MIVCF Treatment Market, UK
• Exhibit 110: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, UK, 2006

CHAPTER 5: ASIA PACIFIC MINIMALLY INVASIVE VERTEBRAL COMPRESSION FRACTURE TREATMENT MARKET

• Exhibit 111: MIVCF Treatment Procedures, Asia Pacific, 2005-2011
• Exhibit 112: MIVCF Treatment Procedures, by Segment, Asia Pacific, 2005-2011
• Exhibit 113: MIVCF Treatment Procedures, by Segment and Country, Asia Pacific, 2005-2011
• Exhibit 114: MIVCF Treatment Levels, by Segment, Asia Pacific, 2005-2011
• Exhibit 115: MIVCF Treatment Market, by Segment, Asia Pacific, (US$), 2005-2011
• Exhibit 116: MIVCF Treatment Market, by Segment and Country, Asia Pacific (US$), 2005-2011
• Exhibit 117: MIVCF Treatment Bone Cement Market, by Segment, Asia Pacific, (US$), 2005-2011
• Exhibit 118: MIVCF Treatment Delivery Systems Market, by Segment, Asia Pacific, (US$), 2005-2011
• Exhibit 119: MIVCF Treatment Bone Cement Market, by Country, Asia Pacific (US$), 2005-2011
• Exhibit 120: MIVCF Treatment Delivery Systems Market, by Country, Asia Pacific (US$), 2005-2011
• Exhibit 121: Drivers and Limiters of the MIVCF Treatment Market, Asia Pacific
• Exhibit 122: Population Division, Total and Over 65, Asia Pacific, 2000-2050
• Exhibit 123: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Asia Pacific, 2006
• Exhibit 124: Leading Competitors in the MIVCF Treatment Market, by Country, as a % of Total, Asia Pacific, 2006
• Exhibit 125: MIVCF Treatment Procedures, by Segment, Australia, 2005-2011
• Exhibit 126: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, Australia, 2005-2011
• Exhibit 127: MIVCF Treatment Levels, by Segment, Australia, 2005-2011
• Exhibit 128: MIVCF Treatment Market, by Segment, Australia (US$ and AU$), 2005-2011
• Exhibit 129: MIVCF Market Growth, by Segment, Australia, 2006-2011
• Exhibit 130: MIVCF Treatment ASP, by Segment and Component, Australia (US$ and AU$), 2005-2011
• Exhibit 131: MIVCF Treatment Bone Cement Market, by Segment, Australia (US$), 2005-2011
• Exhibit 132: MIVCF Treatment Bone Cement Market, by Segment, Australia (AU$), 2005-2011
• Exhibit 133: MIVCF Treatment Delivery Systems Market, by Segment, Australia (US$), 2005-2011
• Exhibit 134: MIVCF Treatment Delivery Systems Market, by Segment, Australia (AU$), 2005-2011
• Exhibit 135: Drivers of the MIVCF Treatment Market, Australia
• Exhibit 136: Limiters of the MIVCF Treatment Market, Australia
• Exhibit 137: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Australia, 2006
• Exhibit 138: MIVCF Treatment Procedures, by Segment, Japan, 2005-2011
• Exhibit 139: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, Japan, 2005-2011
• Exhibit 140: MIVCF Treatment Levels, by Segment, Japan, 2005-2011
• Exhibit 141: MIVCF Treatment Market, by Segment, Japan (US$ and ¥), 2005-2011
• Exhibit 142: MIVCF Treatment Market Growth, by Segment, Japan, 2006-2011
• Exhibit 143: MIVCF Treatment ASP, by Segment and Component, Japan, (US$ and ¥), 2005-2011
• Exhibit 144: MIVCF Treatment Bone Cement Market, by Segment, Japan, (US$), 2005-2011
• Exhibit 145: MIVCF Treatment Bone Cement Market, by Segment, Japan (¥), 2005-2011
• Exhibit 146: MIVCF Treatment Delivery Systems Market, by Segment, Japan (US$), 2005-2011
• Exhibit 147: MIVCF Treatment Delivery Systems Market, by Segment, Japan (¥), 2005-2011
• Exhibit 148: Drivers of the MIVCF Treatment Market, Japan
• Exhibit 149: Limiters of the MIVCF Treatment Market, Japan
• Exhibit 150: Leading Competitors in the MIVCF Treatment Market, as a % of Total, Japan, 2006
• Exhibit 151: MIVCF Treatment Procedures, by Segment, South Korea, 2005-2011
• Exhibit 152: MIVCF Treatment Levels per Procedure, by Segment, as a % of Total, South Korea, 2005-2011
• Exhibit 153: MIVCF Treatment Levels, by Segment, South Korea, 2005-2011
• Exhibit 154: MIVCF Treatment Market, by Segment, South Korea (US$ and W), 2005-2011
• Exhibit 155: MIVCF Market Growth, by Segment, South Korea, 2006-2011
• Exhibit 156: MIVCF Treatment ASP, by Segment and Component, South Korea (US$ and W), 2005-2011
• Exhibit 157: MIVCF Treatment Bone Cement Market, by Segment, South Korea (US$), 2005-2011
• Exhibit 158: MIVCF Treatment Bone Cement Market, by Segment, South Korea (W), 2005-2011
• Exhibit 159: MIVCF Treatment Delivery Systems Market, by Segment, South Korea (US$), 2005-2011
• Exhibit 160: MIVCF Treatment Delivery Systems Market, by Segment, South Korea (W), 2005-2011
• Exhibit 161: Drivers of the MIVCF Treatment Market, South Korea
• Exhibit 162: Limiters of the MIVCF Treatment Market, South Korea
• Exhibit 163: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, South Korea, 2006

APPENDIX B: OSTEOPOROSIS EPIDEMIOLOGY

• Exhibit 164: Prevalence of Osteoporosis, US, 2005-2011
• Exhibit 165: Prevalence of Osteoporosis, France, 2005-2011
• Exhibit 166: Prevalence of Osteoporosis, Germany, 2005-2011
• Exhibit 167: Prevalence of Osteoporosis, Italy, 2005-2011
• Exhibit 168: Prevalence of Osteoporosis, UK, 2005-2011
• Exhibit 169: Prevalence of Osteoporosis, Japan, 2005-2011